BioLargo (BLGO) SEC Filings & 10K Form

$0.33
0.00 (0.00%)
(As of 05/16/2024 ET)

Recent BioLargo SEC Filings

DateFilerForm TypeView
05/15/2024
5:02 AM
BioLargo (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:51 PM
BioLargo (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
2:32 PM
BioLargo (Filer)
Form DEF 14A
04/25/2024
10:37 AM
BioLargo (Filer)
Form 424B4
04/25/2024
10:38 AM
BioLargo (Filer)
Form 424B4
04/23/2024
11:15 PM
BioLargo (Filer)
Form EFFECT
04/23/2024
11:15 PM
BioLargo (Filer)
Form EFFECT
04/23/2024
11:15 PM
BioLargo (Filer)
Form EFFECT
04/15/2024
4:01 PM
BioLargo (Filer)
Form POS EX
04/15/2024
4:02 PM
BioLargo (Filer)
Form POS EX
04/12/2024
4:12 PM
BioLargo (Filer)
Form POS AM
04/12/2024
4:13 PM
BioLargo (Filer)
Form POS AM
04/12/2024
4:16 PM
BioLargo (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/05/2024
6:54 AM
BioLargo (Filer)
Form RW
04/02/2024
4:57 PM
BioLargo (Issuer)
STROMMEN JACK B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
4:51 PM
BioLargo (Issuer)
Park Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
4:29 PM
BioLargo (Issuer)
Marshall Dennis E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
4:40 PM
BioLargo (Issuer)
Bray Christina Elaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
3:45 PM
BioLargo (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/23/2024
8:27 AM
BioLargo (Filer)
Form D
Notice of Exempt Offering of Securities 
01/22/2024
9:15 AM
BioLargo (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
11:12 AM
BioLargo (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
12:05 PM
BioLargo (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
7:03 PM
BioLargo (Issuer)
CODE KENNETH REAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:55 PM
BioLargo (Issuer)
CALVERT DENNIS P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:05 PM
BioLargo (Issuer)
Park Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:17 PM
BioLargo (Issuer)
Bray Christina Elaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:42 PM
BioLargo (Issuer)
Marshall Dennis E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
5:01 AM
BioLargo (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2023
12:28 PM
BioLargo (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/04/2023
12:33 PM
BioLargo (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
5:08 PM
BioLargo (Issuer)
Marshall Dennis E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:17 PM
BioLargo (Issuer)
Park Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:18 PM
BioLargo (Issuer)
Bray Christina Elaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:19 PM
BioLargo (Issuer)
STROMMEN JACK B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:20 PM
BioLargo (Issuer)
CODE KENNETH REAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
3:57 PM
BioLargo (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2023
5:55 PM
BioLargo (Issuer)
CALVERT DENNIS P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2023
12:10 PM
BioLargo (Issuer)
DARGAN CHARLES K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:45 PM
BioLargo (Issuer)
STROMMEN JACK B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:51 PM
BioLargo (Issuer)
CODE KENNETH REAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (Ad)

The AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.

Get the full story here.
07/05/2023
4:23 PM
BioLargo (Issuer)
Marshall Dennis E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
2:03 PM
BioLargo (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2023
2:08 PM
BioLargo (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2023
12:34 PM
BioLargo (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2023
4:05 PM
BioLargo (Filer)
Form 424B4
05/17/2023
8:15 AM
BioLargo (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/16/2023
3:53 PM
BioLargo (Filer)
Form NT 10-Q
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BLGO) was last updated on 5/16/2024 by MarketBeat.com Staff

From Our Partners